𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease)

✍ Scribed by D. Tzonova; O. Larrosa; E. Calvo; J.J. Granizo; A.-M. Williams; Y. de la Llave; D. García-Borreguero

Book ID
116885182
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
188 KB
Volume
13
Category
Article
ISSN
1389-9457

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systematic evaluation of augmentation du
Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom Disease): Results from a prospective, multicenter study over 66 weeks
✍ Diego García-Borreguero; Birgit Högl; Luigi Ferini-Strambi; John Winkelman; Chri 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 915 KB

## Abstract The purpose of this study was to evaluate the incidence of augmentation over 66 weeks of treatment with ropinirole in patients with primary restless legs syndrome (RLS). Augmentation is the main complication of long‐term dopaminergic treatment of RLS. Despite widespread use of ropinirol

Factors contributing to the development
Factors contributing to the development of restless legs syndrome in patients with Parkinson disease
✍ Ji E. Lee; Hae-Won Shin; Kyung S. Kim; Young H. Sohn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

## Abstract Although restless legs syndrome (RLS) commonly accompanies Parkinson disease (PD), the mechanism of RLS development in PD is still unclear. We investigated the prevalence of RLS in Korean patients with PD, and the possible contributing factors to the development of RLS in those patients